WallStSmart
ADMA

ADMA Biologics Inc

NASDAQ: ADMA · HEALTHCARE · BIOTECHNOLOGY

$10.60
-2.75% today

Updated 2026-04-29

Market cap
$2.46B
P/E ratio
17.67
P/S ratio
4.83x
EPS (TTM)
$0.60
Dividend yield
52W range
$7 – $24
Volume
6.8M

ADMA Biologics Inc (ADMA) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$14.65M$14.65M$2.65M$8.69M$12012.00$8079.00$15.56M$31.98M$27.23M$23.71M$23.69M$108.02M$88.88M$127.09M$207.67M$276.25M$348.46M$329.18M$488.68M
Cash & equivalents
Current assets$14.65M$14.65M$2.65M$8.69M$12012.00$8079.00$13.95M$31.05M$24.09M$21.29M$21.66M$63.17M$44.53M$85.82M$153.74M$208.73M$270.40M$257.01M$331.41M
Total liabilities$14.65M$14.65M$2.65M$8.69M$12358.00$5306.00$6.13M$10.41M$21.22M$22.89M$28.14M$67.69M$69.11M$100.90M$119.42M$135.08M$196.49M$193.98M$139.66M
Current liabilities$10.07M$10.07M$15.96M$11.51M$12358.00$5306.00$1.82M$3.66M$4.20M$4.22M$11.22M$9.44M$9.63M$14.03M$19.95M$30.38M$39.27M$49.81M$55.54M
Long-term debt$3.77M$4.87M$14.77M$14.25M$12.32M$28.13M$29.20M$68.29M$92.97M$94.87M$142.83M$130.59M$72.34M
Shareholder equity
Retained earnings$-113596.00$-113596.00$-153557.00$-37.11M$-52.64M$-69.45M$-87.42M$-106.93M$-150.69M$-216.44M$-264.72M$-340.47M$-412.11M$-478.02M$-506.26M$-308.58M
Accounts receivable$-3.50M$39112.00$484423.00$383961.00$924468.00$1.02M$3.88M$1.39M$3.47M$13.24M$28.58M$15.51M$27.42M$50.00M
Inventory$3.40M$1.10M$1.27M$1.67M$1.71M$3.45M$5.02M$12.63M$18.62M$53.06M$81.54M$124.72M$163.28M$172.91M$170.24M
Goodwill$0.00$0.00$0.00$0.00$0.00$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M$3.53M